Beryl Drugs Ltd. - Research Center
524606 BERLDRG Group (XT) BSE data
Add to watchlist
| Results |
Half yearly
|
| Statement | |
| More |
Half yearly results in brief
(Rs crore)
| Sep ' 22 | Mar ' 22 | Sep ' 21 | Sep ' 20 | Mar ' 20 | |
|---|---|---|---|---|---|
| Sales | 12.62 | 6.65 | 7.95 | 5.97 | 5.43 |
| Operating profit | 0.97 | -0.13 | 0.54 | 0.68 | 0.18 |
| Interest | 0.24 | 0.21 | 0.22 | 0.23 | 0.20 |
| Gross profit | 0.99 | -0.26 | 0.39 | 0.99 | 0.03 |
| EPS (Rs) | 1.10 | -1.14 | -0.16 | 0.58 | -0.85 |
Half yearly
results in details
| Sep ' 22 | Mar ' 22 | Sep ' 21 | Sep ' 20 | Mar ' 20 | |
|---|---|---|---|---|---|
| Other income | 0.25 | 0.09 | 0.08 | 0.54 | 0.05 |
| Stock adjustment | -0.02 | -0.39 | 0.08 | -0.37 | -0.06 |
| Raw material | 7.18 | 4.50 | 4.21 | 3.52 | 2.97 |
| Power and fuel | - | - | - | - | - |
| Employee expenses | 0.78 | 0.68 | 0.63 | 0.52 | 0.55 |
| Excise | - | - | - | - | - |
| Admin and selling expenses | - | - | - | - | - |
| Research and development expenses | - | - | - | - | - |
| Expenses capitalised | - | - | - | - | - |
| Other expenses | 3.71 | 1.99 | 2.49 | 1.62 | 1.78 |
| Provisions made | - | - | - | - | - |
| Depreciation | 0.44 | 0.54 | 0.54 | 0.69 | 0.45 |
| Taxation | -0.01 | -0.22 | -0.07 | 0.01 | 0.01 |
| Net profit / loss | 0.56 | -0.58 | -0.08 | 0.29 | -0.43 |
| Extra ordinary item | - | - | - | - | - |
| Prior year adjustments | - | - | - | - | - |
| Equity capital | 5.07 | 5.07 | 5.07 | 5.07 | 5.07 |
| Equity dividend rate | - | - | - | - | - |
| Agg.of non-prom. shares (Lacs) | - | - | - | - | - |
| Agg.of non promotoholding (%) | - | - | - | - | - |
| OPM (%) | 7.72 | -1.99 | 6.79 | 11.43 | 3.34 |
| GPM (%) | 7.66 | -3.82 | 4.90 | 15.25 | .57 |
| NPM (%) | 4.35 | -8.55 | -1.03 | 4.50 | -7.84 |
Mutual Fund Selector
Find the fund that is right for you
© 2023 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback
DISCLAIMER: All financials are on standalone basis